Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $27.09 USD
Change Today -0.39 / -1.42%
Volume 757.6K
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Clive A. Meanwell M.D., Ph.D.

Chairman and Chief Executive Officer, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 20 board members in 4 different organizations across 6 different industries.

See Board Relationships
56$5,193,285
As of Fiscal Year 2014

Background*

Dr. Clive A. Meanwell, M.D., Ph.D. has been the Chief Executive Officer of The Medicines Company since February 2012. Dr. Meanwell served as President of The Medicines Company since October 2009 and served as its Chief Executive Officer from August 2004 to December 2004. Dr. Meanwell served as the President of Targanta Therapeutics Corp. since February 25, 2009. Dr. Meanwell served as Co-Chief Executive Officer and President of Medicines Company from 1996 to September ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

Director
Director
1996-Present
Chairman and Chief Executive Officer
2003-2010
Former Independent Director and Member of Nominating & Governance Committee
2003-Present
Director and Member of Nominating & Governance Committee
2004-Present
Vice Chairman, Chairman of Nomination & Remuneration Committee and Member of Audit Committee
2009-N/A
Former President, Director, Chairman of The Medicines Company and Chief Executive Officer of The Medicines Company

Education*

Unknown/Other Education
University of Birmingham
PhD
University of Birmingham
MD
University of Birmingham

Other Affiliations*

Annual Compensation*

Salary$874,583
Total Annual Compensation$874,583

Stock Options*

Restricted Stock Awards$1,835,505
All Other Compensation$3,354
Exercised Options100,000
Exercised Options Value$1,010,201
Exercisable Options915,692
Exercisable Options Value$7,470,743
Unexercisable Options196,899
Unexercisable Options Value$348,513
Total Value of Options$8,829,456
Total Number of Options1,212,591

Total Compensation*

Total Annual Cash Compensation$1,533,874
Total Short Term Compensation$874,583
Other Long Term Compensation$1,838,859
Total Calculated Compensation$5,193,285
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $27.09 USD -0.39

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James Patrick Mackin Chairman of the Board, Chief Executive Officer and President
CryoLife Inc.
$421.6K
Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
$827.8K
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
€758.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.